Transactions
4
Insider / Merck & Co., Inc.
Rothman Paul
Director at Merck & Co., Inc.
- Company
- Merck & Co., Inc.
- First filing on record
- February 12, 2026
- Latest trade on record
- May 29, 2026
- SEC filings
- EDGAR ↗
Rothman Paul, Director at Merck & Co., Inc., has disclosed 4 transactions in MRK, LH since February 12, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $220K at the reported prices. The latest was filed June 2, 2026, 4 days after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
2.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Rothman Paul reported 4 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 2 | 2,586 | $220K |
| M | Option exercise or conversion | 2 | 1,794 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 4 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MRK | Other A | May 29, 2026 | June 2, 2026 | 4d | 1,853 | $119 | $220K | derivative | Form 4 ↗ | |
| LH | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 897 | — | — | derivative | Form 4 ↗ | |
| LH | Option / conversion M | February 11, 2026 | February 13, 2026 | 2d | 897 | — | — | Form 4 ↗ | ||
| LH | Other A | February 10, 2026 | February 12, 2026 | 2d | 733 | — | — | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 2, 2026 | Form 4 | 0000310158-26-000157 | 1 | published | EDGAR ↗ |
| February 13, 2026 | Form 4 | 0000920148-26-000079 | 2 | published | EDGAR ↗ |
| February 12, 2026 | Form 4 | 0000920148-26-000057 | 1 | published | EDGAR ↗ |
Other insiders at Merck & Co., Inc.
- Karsanbhai Surendralal Lanca Director 30 rows
- Wengel Kathryn E EVP, Chief TO and Risk Officer 24 rows
- Schechter Adam H Director 22 rows
- Wilkinson Peter J SVP, Chief Accounting Officer 22 rows
- Caveney Brian J EVP, Pres of ED, CMO & CSO 20 rows
- Zachary Jennifer EVP, General Counsel 20 rows
- Bailey Megan D. EVP, Pres, Central Labs & Intl 19 rows
- Warden Kathy J Chair, CEO and President 19 rows
- Williams David Michael EVP,Chief Info&Digital Officer 19 rows
- Kyle Kathryn W EVP, Chief Legal Officer 18 rows
Everyone on file, with contracts and lobbying under the company's name: Merck & Co., Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 4 | February 12, 2026 | June 2, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.